Acacia Research (NASDAQ:ACTG – Get Free Report) is expected to issue its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect Acacia Research to post earnings of ($0.14) per share and revenue of $38.00 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, March 11, 2026 at 8:00 AM ET.
Acacia Research Stock Performance
Shares of Acacia Research stock opened at $4.13 on Wednesday. The company has a market cap of $398.38 million, a price-to-earnings ratio of 82.62 and a beta of 0.52. The company has a current ratio of 8.63, a quick ratio of 8.11 and a debt-to-equity ratio of 0.16. The company’s 50-day moving average price is $3.93 and its 200-day moving average price is $3.64. Acacia Research has a 12-month low of $2.70 and a 12-month high of $4.32.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the company. First Trust Advisors LP lifted its position in Acacia Research by 2.8% in the 2nd quarter. First Trust Advisors LP now owns 114,872 shares of the business services provider’s stock valued at $411,000 after acquiring an additional 3,113 shares in the last quarter. Invesco Ltd. boosted its position in shares of Acacia Research by 4.4% during the fourth quarter. Invesco Ltd. now owns 77,143 shares of the business services provider’s stock valued at $289,000 after buying an additional 3,252 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Acacia Research by 22.7% during the second quarter. The Manufacturers Life Insurance Company now owns 19,016 shares of the business services provider’s stock valued at $68,000 after buying an additional 3,517 shares during the last quarter. Geode Capital Management LLC increased its holdings in Acacia Research by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 846,307 shares of the business services provider’s stock worth $3,166,000 after buying an additional 3,525 shares in the last quarter. Finally, Barclays PLC raised its position in Acacia Research by 10.8% in the 4th quarter. Barclays PLC now owns 53,468 shares of the business services provider’s stock worth $200,000 after buying an additional 5,203 shares during the last quarter. Institutional investors own 86.69% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Report on Acacia Research
Acacia Research Company Profile
Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.
The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.
Read More
- Five stocks we like better than Acacia Research
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Acacia Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Research and related companies with MarketBeat.com's FREE daily email newsletter.
